Publication Network
Education Information
2008 - 2012
2008 - 2012Doctorate
University Of New South Wales, Faculty Of Medicine, Prince Of Wales Clinical School, Australia
2002 - 2006
2002 - 2006Undergraduate
Pamukkale University, Faculty Of Arts And Scıences, Department Of Bıology, Turkey
Dissertations
2012
2012Doctorate
Determining Biological Factors Associated with Chemotherapy Response in Glioblastoma Patients
University Of New South Wales
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
Certificates, Courses and Trainings
2008
2008Radiation Safety in Laboratories
Occupational Health and Safety
University of Sydney, Radiation Health Queensland
2006
2006Biyolojik Araştırmalarda Deneysel Hayvanların Kullanımı-IV/Training Program for Animal Use in Experimental Studies
Other
Pamukkale University, Faculty of Medicine
Research Areas
Medicine, Health Sciences, Fundamental Medical Sciences, Medical Biology, Life Sciences, Molecular Biology and Genetics, Moleculer Biology of Cancer, Natural Sciences
Academic Titles / Tasks
2018 - Continues
2018 - ContinuesAssistant Professor
Recep Tayyip Erdogan University, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2013 - 2018
2013 - 2018Assistant Professor
Recep Tayyip Erdogan University, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2013 - 2013
2013 - 2013Research Assistant
Recep Tayyip Erdogan University, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2012 - 2012
2012 - 2012Research Assistant
--Seçiniz--, University Of New South Wales, Lowy Cancer Research Centre
Managerial Experience
2013 - Continues
2013 - ContinuesEthics Committee Member
Recep Tayyip Erdogan University, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2015 - 2016
2015 - 2016Assistant Director of the Institute
Recep Tayyip Erdogan University, Tıp Fakültesi, Sağlık Bilimleri Enstitüsü
Courses
Articles Published in Journals That Entered SCI, SSCI and AHCI Indexes
2022
2022Development of MoS2 and Au nanoparticle including disposable CEA-based immuno-cytosensor platforms
BAL ALTUNTAŞ D. , SEVİM NALKIRAN H. , ASLAN S., YOLCU Z.
CHEMICAL PAPERS, 2022 (Journal Indexed in SCI)
2021
2021Anticancer effects of a novel herbal combination as a potential therapeutic candidate against lung cancer
SAYDAM F. , Nalkiran H.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, vol.48, 2021 (Journal Indexed in SCI)
2020
2020Pelvic Radiation-Induced Testicular Damage: An Experimental Study at 1 Gray.
RAKICI S. , Guzel A. İ. , TUMKAYA L. , Nalkiran H. S. , MERCANTEPE T.
Systems biology in reproductive medicine, vol.66, no.2, pp.89-98, 2020 (Journal Indexed in SCI Expanded)
2019
2019Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis
Nalkiran H. , Sahin S. B. , Ayaz T. , Nalkiran I. , Guzel A. I. , Eldes T., et al.
BIOMARKERS IN MEDICINE, vol.13, no.4, pp.279-289, 2019 (Journal Indexed in SCI)
2019
2019Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
Ha W., Sevim-Nalkiran H. , ZAMAN A. M. , MATSUDA K., Khasraw M., NOWAK A. K. , et al.
SCIENTIFIC REPORTS, vol.9, 2019 (Journal Indexed in SCI)
2017
2017Is neuroglial antigen 2 a potential contributor to cilengitide response in glioblastoma?
Nalkiran H. , MCDONALD K. L.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.13, no.2, pp.329-336, 2017 (Journal Indexed in SCI)
2016
2016Effects of nimesulide on the small intestine mucositis induced by methotrexate in rats
ARSLAN A., ÖZÇİÇEK A., SÜLEYMAN B., ÇOBAN T. A. , CIMEN F. K. , Nalkiran H. , et al.
EXPERIMENTAL ANIMALS, vol.65, no.4, pp.329-336, 2016 (Journal Indexed in SCI)
2016
2016Effects of Nimesulide on Oxidative Mucosal Injury Induced by Cisplatin in Rat Duodenum and Jejunum
ÖZÇİÇEK F., ÇANKAYA M., CIMEN F. K. , Kafa A. H. T. , Nalkiran H. , SÜLEYMAN B., et al.
LATIN AMERICAN JOURNAL OF PHARMACY, vol.35, pp.1110-1115, 2016 (Journal Indexed in SCI)
2016
2016Investigation of mucus obtained from different fish species on the acute pain induced with scalpel incision in paw of rats
Cetin N., SULEYMAN B., KUYRUKLUYILDIZ U., Nalkiran H. , KIRAN A., GENCOGLU S., et al.
EXPERIMENTAL ANIMALS, vol.65, no.1, pp.77-85, 2016 (Journal Indexed in SCI)
2011
2011Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?
Sevim H. , Parkinson J. F. , McDonald K. L.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.137, no.11, pp.1705-1712, 2011 (Journal Indexed in SCI)
Articles Published in Other Journals
2021
2021Comparison of DNA isolation methods from mammalian sperm cells and development of a new protocol
Sevim Nalkıran H. , Nalkıran İ. , Rakıcı S. , Tümkaya L. , Güzel A. İ.
Medicine Science, vol.10, no.2, pp.440-443, 2021 (Other Refereed National Journals)
2018
2018Effects of Hippophae rhamnoides extract on oxidative mucosal injuryinduced by cisplatin in rat jejunum.
Arslan A., ÖZÇİÇEK F., KESKİN ÇİMEN F., SEVİM H. , GÜLABOĞLU M., ÇETİN N., et al.
Biomedical Research-India, vol.29, no.2, pp.401-407, 2018 (Refereed Journals of Other Institutions)
2007
2007?Prevention of Carbon Tetrachloride-Induced Hepatotoxicity by Urtica urens in Rats.
Sen A., Şahin B., Agus H. H. , Bayav M., SEVİM NALKIRAN H. , Semiz A.
JOURNAL OF APPLIED BIOLOGICAL SCIENCES, vol.1, no.3, pp.29-32, 2007 (Other Refereed National Journals)
Refereed Congress / Symposium Publications in Proceedings
2021
2021Investigation of PD-L1 Gene Expression in Bladder Cancer Tissues
Durur S., Uzun H. , Bedir R. , Nalkıran İ. , Sevim Nalkıran H.
8th Multidisciplinary Cancer Research Congress, 16 - 17 January 2021, pp.102
2019
2019Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis
Sevim Nalkıran H.
Eurasian Congress on Molecular Biotechnology, Trabzon, Turkey, 19 - 21 September 2019, pp.17
2017
2017Polikistik Over Sendromu Tanısı Almış Hastalarda Paraoksonaz 1 Genindeki Leu55Met ve Gln192Arg Polimorfizmlerinin Ateroskleroz riskiyle ilişkisinin Araştırılması
SEVİM NALKIRAN H. , AYAZ T. , NALKIRAN İ. , GÜZEL A. İ. , ELDEŞ T. , YILDIZ Y.
2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu, Turkey, 23 - 25 February 2017
2017
2017Y CHROMOSOME MICRODELTIONS IN 102 CASES: IS THE INCIDENCE OF ACQUIRED NON-OBSTRUCTIVE AZOOSPERMIA INCREASING?
UZUN H. , SEVİM NALKIRAN H. , AKÇA N. , EREN H., NALKIRAN İ. , SAYDAM F. , et al.
ESAU Meeting Bodrum Turkey, Muğla, Turkey, 21 May 2017, pp.84
2017
2017Polikistik over sendromu tanısı almış hastalarda paroksinaz 1 genindeki Leu55met ve Gln192arg polimorfizmlerinin ateroskleroz riskiyle ilişkilerinin araştırılması
SEVİM NALKIRAN H. , AYAZ T. , ELDEŞ T.
2.Ege Endokrin Hastalıklar Ve Genetik Sempozyumu, Turkey, 23 - 25 May 2017
2017
2017EFFECT OF SORTILIN GEN EXPRESSION ON LDL SUBFRACTIONS AND SEVERITY OF CORONARY ARTERY DISEASE
UYDU H. A. , ATAK M., BOSTAN M. , SEVİM NALKIRAN H. , MALKOÇ M., PINARBAŞ E., et al.
85th Congress of the European Atherosclerosis Society, Brisbane, Australia, 23 - 26 April 2017, vol.11, no.263, pp.0-104
2017
2017Simultane Familyal Glioblastom: İki Kardeş Glioblastom Vakası
RAKICI S. , SEVİM NALKIRAN H. , ÇETİN B. , BEDİR R.
22. ULUSAL KANSER KONGRESİ, Antalya, Turkey, 19 - 23 April 2017, pp.153
2017
2017Investigation of Association Between Paraoxonase-1 L55M (RS854560) and Q192R (RS662) Polymorphisms and Potential Atherosclerotic Risk Factors in PCOS Patients Patients (Polikistik Over Sendromu Tanısı Almış Hastalarda Paraoksonaz 1 Genindeki Leu55Met ve Gln192Arg Polimorfizmlerinin Ateroskleroz riskiyle ilişkisinin Araştırılması)
SEVİM NALKIRAN H. , AYAZ T. , NALKIRAN İ., GÜZEL A. İ. , DURAKOĞLUGİL T. , YILDIZ Y.
2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu, İzmir, Turkey, 23 - 25 February 2017, vol.9, pp.27
2016
2016Repurposing Ibudilast in combination with temozolomide for glioblastoma
McDonald K., Ha W., SEVİM NALKIRAN H. , Khasraw M.
21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, Scottsdale, Arizona, Arizona, United States Of America, 17 - 20 November 2016, vol.18
2016
2016Repurposing Ibudilast in combination with temozolomide for glioblastoma
McDonald K., Ha W., SEVİM NALKIRAN H. , Chung L., Baxter R., Khasraw M.
13th Asian Society for Neuro-Oncology (ASNO) Meeting/9th COGNO Annual Scientific Meeting, Sydney, Australia, 11 - 14 September 2016, pp.67
2014
2014MIF/CD74 guided therapeutic strategy for relapsed glioblastoma patients
Mcdonald K. L. , SEVİM NALKIRAN H. , Ha W., Chung L., Baxter R.
105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), California, United States Of America, 5 - 09 April 2014, vol.74
2014
2014MIF-CD74 GUIDED THERAPEUTIC STRATEGY FOR THE UPFRONT TREATMENT OF GBM PATIENTS WITH AN UNMETHYLATED MGMT PROMOTER
McDonald K. L. , Ha W., Sevim H.
20th International Conference on Brain Tumor Research and Therapy, California, United States Of America, 20 - 22 July 2014, vol.16
2013
2013Improved Responsiveness to Temozolomide by Blocking MIF Expression in Glioblastoma
McDonald K. L. , SEVİM NALKIRAN H.
Worldwide Innovative Networking in Personalized Cancer Medicine WIN 2013 Symposium-Personal Cancer Medicine: From Innovation to implementation, Paris, France, 10 - 12 July 2013, pp.7
2012
2012Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival?
SEVİM NALKIRAN H. , Chung L., Wheeler H. R. , Baxter R. C. , McDonald K. L.
European Association of Neuro-oncology (EANO) 10th meeting, Marsilya, France, 6 - 07 September 2012, no.14
2011
2011Aberrant expression of Low-molecular-weight proteins associated with response to conventional concurrent chemoradiotherapy treatment
SEVİM NALKIRAN H. , Chung L., Wheeler H. R. , Baxter R. C. , McDonald K. L.
16th Annual Scientific Meeting & Education Day of the Society for Neuro-Oncology, Garden Grove, United States Of America, 17 - 20 November 2011, vol.13
2011
2011Protein biomarker discovery in glioblastoma using SELDI-TOF-MS
SEVİM NALKIRAN H. , Chung L., Wheeler H. R. , Baxter R. C. , McDonald K. L.
102nd Annual Meeting of the American Association for Cancer Research, Orlando, United States Of America, 2 - 06 April 2011, vol.71, no.5094, pp.71
2010
2010?Determining Biological Factors Associated with chemotherapy response in Glioblastoma Patients
SEVİM NALKIRAN H. , Maleki S., Messina M., Robinson B. G. , McDonald K. L.
22nd Lorne Cancer Conference, Lorne-Melbourne, Australia, 11 - 13 February 2010, pp.24
2009
2009Determining Biological Factors Associated with chemotherapy response in Glioblastoma Patients?
SEVİM NALKIRAN H. , Maleki S., Messina M., Robinson B. G. , McDonald K. L.
XXVIth Annual Scientific Research Meeting, Sydney, Australia, 25 November 2009, pp.51
2006
2006In vivo effects of Urtica urens seed extracts on the cytochrome P450-dependent monooxygenases in the liver, lung and kidney of control and 3-methylcholanthrene-exposed rats
SEN A., Agus H. H. , Bayav M., SEVİM NALKIRAN H.
14th North American ISSX Meeting, Puerto Rico, United States Of America, 22 - 26 October 2006, vol.38, pp.55-56
2006
2006Karaciğer Koruyucu Urtica urens: Sıçanlarda Karbontetraklorür?ün Neden Olduğu Karaciğer Toksisitesinin U. urens ile Giderilmesi
Sen A., Şahin B., Bayav M., Agus H. H. , SEVİM NALKIRAN H. , Semiz A.
18. Ulusal Biyoloji Kongresi, Aydın, Turkey, 26 - 30 June 2006, no.154, pp.59
2006
2006In vivo assessment of Urtica urens supplementation on rat xenobiotic metabolizing enzymes
Sen A., Agus H. H. , Bayav M., SEVİM NALKIRAN H.
Federation of European Biochemical Societies, İstanbul, Turkey, 25 - 29 June 2006, vol.273, pp.300
Books & Book Chapters
2021
2021Otizm Spektrum Bozuklukları ve Sinema Terapi
SEVİM NALKIRAN H.
in: TIP ve SANAT, Doç. Dr. Sema Yılmaz Rakıcı, Editor, Akademisyen Kitabevi, Ankara, pp.83-106, 2021
Supported Projects
2020 - Continues
2020 - Continues
Lavandula stoechas esansiyel yağ ve özütünün kanser hücreleri üzerinde potansiyel sitotoksik ve anti-metastatik etkilerinin araştırılması
Project Supported by Higher Education Institutions
(Project Abstract)
SEVİM NALKIRAN H. (Executive) , NALKIRAN İ.
2020 - 2023
2020 - 2023
XX Sinyal Yolağı Hedeflenmesinin Potansiyel Bir Kanser İmmünoterapi Yaklaşımı Olarak Araştırılması
TUBITAK Project
Sevim Nalkıran H. (Executive) , Nalkıran İ.
2020 - 2021
2020 - 2021
Mesane Kanseri Hastalarında PD1 ve PDL1 Ekspresyonlarının Prognostik Öneminin İncelenmesi
Project Supported by Higher Education Institutions
SEVİM NALKIRAN H. (Executive) , Durur S.
2017 - 2020
2017 - 2020
Mesane kanseri hücrelerinin standart kemoterapi rejimi ve inhibitör içeren kombine terapiye karşı cevabının araştırılması
Project Supported by Higher Education Institutions
SEVİM NALKIRAN H. (Executive) , NALKIRAN İ. , SAYDAM F. , GÜZEL A. İ.
2014 - 2018
2014 - 2018Koroner Arter Hastalarında Sortilin Gen Bölgesiyle İlişkili Non-coding rs599839 Gen Polimorfizimin Lipoprotein Alt Fraksiyonlar İle Olan İlişkisinin İncelenmesi
Project Supported by Higher Education Institutions
UYDU H. A. (Executive) , PINARBAŞ E. , AKYILDIZ K. , ATAK M. , SEVİM NALKIRAN H. , HÜNER M.
2014 - 2017
2014 - 2017Düşük doz radyasyonun germ hücrelerinde oluşturduğu genetik ve histopatolojik değişiklikler.
Project Supported by Higher Education Institutions
RAKICI S. (Executive) , TÜMKAYA L. , GÜZEL A. İ. , SEVİM NALKIRAN H.
2013 - 2017
2013 - 2017Polikistik over sendromu tanısı almış hastalarda paraoksonaz 1 genindeki Leu55Met ve Gln192Arg polimorfizmlerinin ateroskleroz riskiyle ilişkisinin araştırılması
Project Supported by Higher Education Institutions
SEVİM NALKIRAN H. (Executive) , NALKIRAN İ. , AYAZ T. , GÜZEL A. İ.
Edit Congress and Symposium Activities
2020
2020
Eurasian Congress on Molecular Biotechnology
Invited Speaker
Trabzon-Turkey
2012
2012Clinical Oncological Society of Australia (COSA) Neuro-Oncology Clinical Professional Day
Attendee
Sydney-Australia
2011
2011The 16th Annual Scientific Meeting of the Society for Neuro-Oncology in Colloboration with the AANS/CMS Section on Tumors (MCOS 1002)
Attendee
California-United States Of America
Scholarships
2006 - 2012
2006 - 20121416 Sayılı Kanun Uyarınca Yurtdışında Lisansüstü Öğrenim Bursu
Ministry of Education
2011 - 2011
2011 - 2011Round 1, Prince of Wales Clinical School (POWCS)
University
2011 - 2011
2011 - 2011Round 1, Postgraduate Research Support Scheme (PRSS)
University
2010 - 2010
2010 - 201022nd Lorne Cancer Conference travel award
Other International Organizations
Jury Memberships
April-2020
April 2020